3650-- TheraSphere Doses for 2020-2021
Special Notice Posted
- Solicitation number
- 36C25020Q0774
- Agency
- Veterans Integrated Service Network 10 Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 published a Special Notice to award a sole source contract. The Network Contracting Office for the Cleveland VA Medical Center intends to provide a 12-month supply of 15 TheraSphere radiopharmaceutical doses from BTG International Canada Inc. for treating liver cancer at the Nuclear Medicine Department.
The Special Notice aims to procure a proprietary supply of TheraSphere doses to treat hepatocellular carcinoma through simplified commercial item procedures. Any business that believes it can provide the doses must submit notice by June 24, 2020 to be considered for award, however no competitive solicitation will be issued as this is a sole source procurement for the exclusive license holder. A justification cites BTG as the sole distributor and notes no other resellers were found during market research. The estimated contract value is $255,000 to provide 15 doses over one year for radioactive therapy of veterans with liver cancer at the Cleveland VA Medical Center.
Notice text
NOTICE OF INTENT TO SOLE SOURCE
THERASPHERE RADIOPHARMACEUTICAL DOSES
The Network Contracting Office (NCO) 10 for the Cleveland Louis Stokes VA Medical Center, 10701 East Blvd, Cleveland, OH 44131 intends to award a sole source under the authority of FAR 6.302-1(a)(2), Only one responsible source and no other supplies or services will satisfy agency requirements The Contractor will provide a Firm Fixed Priced, twelve-month supply of Therasphere; these Radiopharmaceutical Doses will be used in the Nuclear Medicine Department at the Cleveland VA Medical Center.
Therasphere Radiopharmaceutical Doses 15 EA used to treat liver cancer
Determination of this sole source procurement is in accordance with FAR 13.106-1(2)(b) soliciting from one source. It is the Government s belief that the proposed candidate is the only provider of the proprietary Radiopharmaceutical Doses. This notice of intent is not a request for competitive quotes. No solicitation documents are available and telephone requests will not be accepted. However, any business that believes it can provide the supplies may submit written notice to john.tschirhart@va.gov 4:00pm EST on June 24, 2020
Attachments
| File | Type | Posted |
|---|---|---|
| FAR6_JA_OVER_SAT.pdf | ||
| 36C25020Q0774.docx | DOCX document |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity